muramidase and Trichomonas-Vaginitis

muramidase has been researched along with Trichomonas-Vaginitis* in 10 studies

Reviews

1 review(s) available for muramidase and Trichomonas-Vaginitis

Article	Year
Innate host defense of human vaginal and cervical mucosae. Current topics in microbiology and immunology, 2006, Volume: 306 Host defense responses of the human female genital tract mucosa to pathogenic microbes and viruses are mediated in part by the release of antimicrobial substances into the overlying mucosal fluid. While host defense has long been considered a prominent function of vaginal and cervical mucosae, evidence that cationic antimicrobial peptides and proteins have fundamental roles in the innate host defense of this tissue has only recently become available. This chapter explores elements of the physical and chemical defense barriers of the cervicovaginal mucosa, which protect against infections of the lower genital tract. Cationic antimicrobial and antiviral polypeptide components of cervicovaginal fluid are discussed in detail, with special emphasis placed on the defensin family of peptides as well as polypeptides that are active against viruses such as HIV-1. The reader should be cognizant that each polypeptide by itself does not provide complete protection of the genital tract. On the contrary, the abundance and multiplicity of antimicrobial peptides and proteins suggest protection of the cervicovaginal mucosa may be best realized from the aggregate effector molecules. Topics: Acquired Immunodeficiency Syndrome; Antimicrobial Cationic Peptides; Candidiasis, Vulvovaginal; Cathelicidins; Cervix Uteri; Defensins; Female; Histones; Humans; Immunity, Innate; Lactoferrin; Leukocyte L1 Antigen Complex; Muramidase; Proteinase Inhibitory Proteins, Secretory; Proteins; Trichomonas Vaginitis; Vagina; Vaginosis, Bacterial	2006

Article

Year

Innate host defense of human vaginal and cervical mucosae.

Current topics in microbiology and immunology, 2006, Volume: 306

Host defense responses of the human female genital tract mucosa to pathogenic microbes and viruses are mediated in part by the release of antimicrobial substances into the overlying mucosal fluid. While host defense has long been considered a prominent function of vaginal and cervical mucosae, evidence that cationic antimicrobial peptides and proteins have fundamental roles in the innate host defense of this tissue has only recently become available. This chapter explores elements of the physical and chemical defense barriers of the cervicovaginal mucosa, which protect against infections of the lower genital tract. Cationic antimicrobial and antiviral polypeptide components of cervicovaginal fluid are discussed in detail, with special emphasis placed on the defensin family of peptides as well as polypeptides that are active against viruses such as HIV-1. The reader should be cognizant that each polypeptide by itself does not provide complete protection of the genital tract. On the contrary, the abundance and multiplicity of antimicrobial peptides and proteins suggest protection of the cervicovaginal mucosa may be best realized from the aggregate effector molecules.

Topics: Acquired Immunodeficiency Syndrome; Antimicrobial Cationic Peptides; Candidiasis, Vulvovaginal; Cathelicidins; Cervix Uteri; Defensins; Female; Histones; Humans; Immunity, Innate; Lactoferrin; Leukocyte L1 Antigen Complex; Muramidase; Proteinase Inhibitory Proteins, Secretory; Proteins; Trichomonas Vaginitis; Vagina; Vaginosis, Bacterial

2006

Trials

3 trial(s) available for muramidase and Trichomonas-Vaginitis

Article	Year
[Preliminary clinical trials of pentamycin]. La Clinica terapeutica, 1980, Jan-31, Volume: 92, Issue:2 Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Macrolides; Metronidazole; Muramidase; Polyenes; Trichomonas Vaginitis	1980
[Controlled study of a new treatment of mycotic and protozoan vaginitis]. Minerva ginecologica, 1973, Volume: 25, Issue:1 Topics: Adult; Candida albicans; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Metronidazole; Muramidase; Nystatin; Suppositories; Trichomonas vaginalis; Trichomonas Vaginitis	1973
[The use of a new drug (Deflamon) in the treatment of vaginal trichomoniasis]. Minerva ginecologica, 1968, Jan-15, Volume: 20, Issue:1 Topics: Female; Humans; Metronidazole; Muramidase; Pregnancy; Pregnancy Complications, Infectious; Trichomonas Vaginitis	1968

Other Studies

6 other study(ies) available for muramidase and Trichomonas-Vaginitis

Article	Year
[Clinical experience in the therapy of mycotic and protozoan vaginitis]. Rivista italiana di ginecologia, 1970, Volume: 54, Issue:4 Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Drug Tolerance; Female; Humans; Metronidazole; Middle Aged; Muramidase; Nystatin; Suppositories; Trichomonas Vaginitis	1970
[On the use of a new drug in the treatment of vaginal trichomona infections]. Hospital (Rio de Janeiro, Brazil), 1969, Volume: 75, Issue:4 Topics: Female; Humans; Metronidazole; Muramidase; Trichomonas Vaginitis	1969
[Current status and prospects of therapy of vaginal trichomoniasis]. Minerva ginecologica, 1969, Oct-15, Volume: 21, Issue:19 Topics: Adolescent; Adult; Drug Combinations; Female; Humans; Metronidazole; Middle Aged; Muramidase; Trichomonas Vaginitis	1969
[Deflamon in the therapy of trichomoniasis]. Minerva ginecologica, 1969, Oct-15, Volume: 21, Issue:19 Topics: Drug Combinations; Female; Humans; Metronidazole; Muramidase; Trichomonas Vaginitis	1969
[Lysozyme content in the vaginal environment]. Gynaecologia. International monthly review of obstetrics and gynecology. Revue internationale mensuelle d'obstetrique et de gynecologie. Monatsschrift fur Geburtshilfe und Gynakologie, 1967, Volume: 164, Issue:6 Topics: Bacteriolysis; Biological Assay; Female; Humans; Micrococcus; Muramidase; Spectrophotometry; Trichomonas Vaginitis; Vagina	1967
[Therapeutic possibilities of lysozyme in trichomonas vaginitis]. Minerva ginecologica, 1960, Nov-15, Volume: 12 Topics: Anti-Infective Agents, Local; Female; Humans; Muramidase; Trichomonas Infections; Trichomonas Vaginitis; Vaginitis; Vulvovaginitis	1960